Explain why bone turnover markers are not useful for predicting bone loss (in untreated patients).
Articulate two ways to define response to bisphosphonate therapy using bone turnover markers
Describe the rationale for potentially using bone turnover markers to monitor adherence to bisphosphonate therapy and to monitor offset of treatment effect after discontinuation of bisphosphonate therapy
Participants should be aware of the following financial/non-financial relationships:
Albert Shieh, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
